Rx Price Markups & Insurance Watch: What Headlines Claim vs. What the Data Really Shows.

Let’s strip away the jargon and look at the actual federal receipts. Every week, the Centers for Medicare & Medicaid Services (CMS) publishes the National Average Drug Acquisition Cost (NADAC)—the real, audited wholesale invoice price that U.S. brick-and-mortar pharmacies pay to put pills on their shelf. When we cross-referenced CMS NADAC invoices against JAMA Internal Medicine claim audits (PMID 38416590), we found that 10 of America’s most prescribed generics cost pharmacies between $0.90 and $2.94 per month—yet insured patients routinely pay $15 to $30 copays, and uninsured walk-in patients get hit with $48 to $140 bills (up to a 1,840% markup).